What is the pathogenesis of the unusual thrombotic events and thrombocytopenia that can develop after vaccination with the AstraZeneca coronavirus disease 2019 (COVID-19) vaccine?
What is the risk of subsequent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among young adults seropositive for a previous infection?